DEFRATAJ 400 mg

Deferasirox Dispersible Tablet

Tablet manufacturing line producing DEFRATAJ 400 mg dispersible tablets
Tablet manufacturing line, Taj Pharma WHO-GMP facility (Sarigam).
Product NameDeferasirox Dispersible Tablet 400 mg
Brand NameDEFRATAJ
Strength400 mg
Dosage FormDispersible Tablet
Route of AdministrationOral (after dispersion)
Packing10 x 10 PVC/PVDC-Aluminium blisters; HDPE bottles available; custom pack sizes for tenders
Shelf Life24-36 months (market-specific)
Therapeutic UseIron chelator (ATC: V03AC03) for chronic transfusional iron overload
IndicationTreatment of chronic iron overload due to frequent blood transfusions in adolescent and adult patients with beta-thalassemia major, sickle-cell disease and MDS where higher daily doses are clinically required.
StorageStore below 30 degrees C. Protect from moisture.
CompositionEach dispersible tablet contains: Deferasirox 400 mg.
Excipients: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone K30, sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate.
Tablet DescriptionOff-white to pale yellow, oblong/round, flat, uncoated tablet with break-line; disperses in water or juice within ~3 minutes.

Full Excipient Breakdown

ExcipientFunction
Lactose monohydrateDiluent
Microcrystalline celluloseDiluent / binder
CrospovidoneDisintegrant
Povidone K30Binder
Sodium lauryl sulfateWetting agent
Colloidal silicon dioxideGlidant
Magnesium stearateLubricant

Dosage Instructions

Disperse in 100-200 ml water/juice; drink immediately. Once daily, empty stomach, same time daily. Useful in patients requiring 30-40 mg/kg/day where pill burden would otherwise be high.

Caution & Warning

Schedule H drug. Sold by prescription only. Monitor renal/hepatic function. Discontinue on signs of SJS/TEN/DRESS or organ failure. Not for use when CrCl < 60 mL/min. Higher doses warrant closer monitoring of creatinine and liver enzymes.

Overdose

No specific antidote. Supportive management. Dialysis unlikely effective.

Disposal

Dispose per local pharmaceutical-waste regulations.


The 400 mg strength reduces tablet burden in adult patients on higher daily doses, supporting adherence over long-term therapy.

Schedule H: To be sold by retail on the prescription of a Registered Medical Practitioner only. Not all pack sizes may be marketed.